Device maker Nemera and Nelson Labs have announced the expansion of an existing partnership, with Nelson Labs performing microbiological and chemical analyses, extractables and leachables testing, and biocompatibility studies for Nemera customers. Nemera is an associate member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS).
Nelson Labs Senior VP, EMEAA, Eric Meyers said, “We’re very happy that we can offer our lab testing services and associated scientific knowledge to a company like Nemera where we share the same premise of improving the lives of patients worldwide. We are convinced that by combining our forces we will bring many benefits to both the end customer and ultimately the patient.”
Nemera CEO Marc Hämel commented, “We’ve been relying on Nelson Labs’ expertise for several years now. This announcement comes at the perfect time for Nemera as we passionately grow our business as an integrated services partner. Our goal is to bring the most benefits possible when it comes to front-end innovation and device development, clinical and commercial device manufacturing and combination product services to customers and ultimately patients.”
Read the Nemera press release.
